Summary
The acetylator phenotype and ABO blood groups were evaluated in 55 normal subjects and in 156 diabetic patients [61 with Type 1 (insulin-dependent) diabetes and 95 with Type 2 (non-insulin-dependent) diabetes]. The prevalence of fast acetylators was significantly higher in the Type 1 diabetic patients (53%) than in the control subjects (29%). In the Type 2 diabetic patients the prevalence was 39%, and thus not signifi cantly different from the control or Type 1 diabetic groups. In the Type 2 diabetic patients, but not in the control or in the Type 1 diabetic subjects, an association between the fast acetylator phenotype and the B blood group was found.
Article PDF
Avoid common mistakes on your manuscript.
References
Mattila MJ, Tiitenen M (1967) The rate of isoniazid inactivation in Finnish diabetic and non-diabetic patients. Ann Med Exp Biol Fenn 45: 423–427
Burrows AW, Hockaday TDR, Mann JI, Taylor JG (1978) Diabetic dimorphism according to acetylator status. Br Med J1: 208–210
Bodansky HJ, Drury PL, Cudworth AG, Evans DAP (1981) Acetylator phenotypes and Type 1 (insulin-dependent) diabetics with micro-vascular disease. Diabetes 30: 907–910
Miller WU (1977) Technical manual of the American Association of Blood Banks, 7th ed, American Association of Blood Banks, Washington, pp 85–96
Mosca A, Carenini A, Samaja M, Saibene V (1980) Temperature control in assay of glycosylated haemoglobin. Clin Chem 26: 1106
Schlichtkrall J, Munck O, Jerslid M (1965) The M value, an index of blood sugar control in diabetics. Acta Med Scand 177: 95–102
Evans DAP, White TA (1964) Human acetylation polymorphism. J Lab Clin Med 63: 394–403
Evans DAP (1969) An improved and simplified method of detecting the acetylator phenotype. J Med Genet 6: 405–407
Varley M (1954) Practical clinical biochemistry. Heinemann Medical Books, London, pp 632–636
Vree TB, O'Reilly WJ, Hekster YA, Damsma JE, van der Kleijn E (1980) Determination of acetylator phenotype and pharmaco kinetics of some sulphonamides in man. Clin Pharmacokinet 5: 274–294
Evans DAP, Manley KA, McUsick VA (1960) Genetic control of isoniazid metabolism in man. Br Med J 2: 485–491
Sunahara S, Urano KA, Ogawa M (1961) Genetical and geographic studies on isoniazid inactivation. Science 134: 1530–1531
Lunde PKM, Frislid K, Hansteen V (1977) Disease and acetylation polymorphism. Clin Pharmacokinet 2: 182–197
Shenfield GM, McCann VJ, Tjokresetio R (1982) Acetylation status and diabetic neuropathy. Diabetologia 22: 441–444
Ladero JM, Arrojo A, de Salamanca RE, Gomez M, Cano F, Alfonso M (1982) Hepatic acetylator phenotype in diabetes mellitus. Ann Clin Res 14: 187–189
Thom S, Farrow PR, Santoso B, Alberti KGMM, Rawlins MD (1981) Effects of oral glucose on isoniazid kinetics. Br J Clin Pharmacol 11: 423
Olsen H, Morland J (1978) Ethanol induced increase in drug acetylation in man and isolated rat liver cells. Br Med J 2: 1260–1262
McConnel RB, Pyke DA, Fraser Roberts JA (1956) Blood groups in diabetes mellitus. Br Med J 1: 772–776
Vague PH, Melis C, Mercier P, Vialettes B, Lassmann V (1978) The increased frequency of the Lewis negative blood group in a diabetic population. Diabetologia 15: 33–36
Leslie RDG, Pyke DA (1979) Letter to the Editor. Diabetologia 16: 139
Hodge SE, Neiswanger K, Spence MA, Sparker MC, Terasaki PI, Anderson CE, Field LL, Sparker RR, Crist M, Rimoin DL, Rotter JI (1981) Close genetic linkage between diabetes mellitus and the Kidd blood group. Lancet 2: 893–895
Rotter JI, Rimoin DL (1979) Diabetes mellitus: the search for genetic markers. Diabetes Care 2: 215–226
Pyke DA (1979) Diabetes: the genetic connections. Diabetologia 17: 333–349
Cudworth AG (1981) Types of diabetes and their pathogenesis. In: Randle PJ, Steiner DF, Whelan WJ (eds) Carbohydrate metabolism and its disorders, vol 3. Academic Press, London, pp 229–277
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Pontiroli, A.E., Mosca, A., de Pasqua, A. et al. The fast acetylator phenotype in diabetes mellitus: abnormal prevalence and association with the ABO blood groups. Diabetologia 27, 235–237 (1984). https://doi.org/10.1007/BF00273812
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00273812